• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lexaria Bioscience Corp. - Common Stock (NQ:LEXX)

0.7097 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,725
Open 0.7097
Bid (Size) 0.6800 (5,000)
Ask (Size) 0.6975 (300)
Prev. Close 0.7097
Today's Range 0.7097 - 0.7097
52wk Range 0.4600 - 2.430
Shares Outstanding 22,225,846
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-4
December 30, 2025
Via ACCESS Newswire
News headline image
In today's session, these stocks are experiencing unusual volume. ↗
December 26, 2025
Unusual volume stocks are being observed in Friday's session. 
Via Chartmill

Performance

YTD
+8.5%
+8.5%
1 Month
-34.9%
-34.9%
3 Month
-15.5%
-15.5%
6 Month
-18.8%
-18.8%
1 Year
-67.4%
-67.4%

More News

Read More
News headline image
Unusual volume stocks are being observed in Wednesday's session. ↗
December 24, 2025
Via Chartmill
News headline image
Primary Endpoint Successfully Achieved in Lexaria's Phase 1b Study GLP-1-H24-4
December 23, 2025
Via ACCESS Newswire
News headline image
Lexaria Bioscience Corp. Announces Closing of $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
December 16, 2025
Via ACCESS Newswire
News headline image
Which stocks are moving on Monday? ↗
December 15, 2025
Via Chartmill
News headline image
Which stocks are gapping on Monday? ↗
December 15, 2025
Via Chartmill
News headline image
Monday's pre-market session: top gainers and losers ↗
December 15, 2025
Via Chartmill
News headline image
Lexaria Bioscience Corp. Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
December 15, 2025
Via ACCESS Newswire
News headline image
Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended
November 12, 2025
Via ACCESS Newswire
News headline image
Lexaria Bioscience Corp. Provides Strategic Update
October 09, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
October 02, 2025
Via Benzinga
News headline image
Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
September 29, 2025
Via ACCESS Newswire
News headline image
Keep an eye on the top gainers and losers in Friday's session. ↗
September 26, 2025
Via Chartmill
News headline image
Nasdaq Gains 100 Points; US Consumer Sentiment Falls ↗
September 26, 2025
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
September 26, 2025
Via Benzinga
News headline image
Which stocks are experiencing notable movement on Friday? ↗
September 26, 2025
Via Chartmill
News headline image
Friday's session: gap up and gap down stocks ↗
September 26, 2025
Via Chartmill
News headline image
Dow Jumps Over 250 Points; Fed's Key Inflation Gauge Remains Hot ↗
September 26, 2025
Via Benzinga
Topics Economy Stocks
News headline image
What's going on in today's pre-market session ↗
September 26, 2025
Via Chartmill
News headline image
Lexaria Bioscience Corp. Announces $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
September 26, 2025
Via ACCESS Newswire
News headline image
Why Top KingWin Shares Are Trading Higher By 87%; Here Are 20 Stocks Moving Premarket ↗
September 26, 2025
Via Benzinga
Topics Artificial Intelligence
News headline image
Why Are Lexaria Bioscience Shares Soaring 45% After Hours? ↗
September 26, 2025
Via Benzinga
News headline image
Lexaria's Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain
September 19, 2025
Via ACCESS Newswire
News headline image
Lexaria Attending the 27th Annual H.C. Wainwright Global Investment Conference
August 27, 2025
Via ACCESS Newswire

Frequently Asked Questions

Is Lexaria Bioscience Corp. - Common Stock publicly traded?
Yes, Lexaria Bioscience Corp. - Common Stock is publicly traded.
What exchange does Lexaria Bioscience Corp. - Common Stock trade on?
Lexaria Bioscience Corp. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lexaria Bioscience Corp. - Common Stock?
The ticker symbol for Lexaria Bioscience Corp. - Common Stock is LEXX on the Nasdaq Stock Market
What is the current price of Lexaria Bioscience Corp. - Common Stock?
The current price of Lexaria Bioscience Corp. - Common Stock is 0.7097
When was Lexaria Bioscience Corp. - Common Stock last traded?
The last trade of Lexaria Bioscience Corp. - Common Stock was at 01/05/26 04:00 PM ET
What is the market capitalization of Lexaria Bioscience Corp. - Common Stock?
The market capitalization of Lexaria Bioscience Corp. - Common Stock is 15.77M
How many shares of Lexaria Bioscience Corp. - Common Stock are outstanding?
Lexaria Bioscience Corp. - Common Stock has 16M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap